Fifth Third Wealth Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$498K Buy
4,515
+151
+3% +$14.6K 0.01% 527
2026
Q2
$342K Sell
4,364
-583
-12% -$39.8K 0.01% 646
2026
Q1
$320K Buy
4,947
+733
+17% +$51.7K 0.01% 574
2025
Q4
$284K Sell
4,214
-45
-1% -$3.03K 0.01% 609
2025
Q3
$312K Sell
4,259
-35
-0.8% -$2.32K 0.01% 538
2025
Q2
$223K Buy
4,294
+13
+0.3% +$740 0.01% 664
2025
Q1
$273K Buy
4,281
+16
+0.4% +$929 0.01% 527
2024
Q4
$204K Sell
4,265
-65
-2% -$3.33K 0.01% 692
2024
Q3
$248K Buy
4,330
+34
+0.8% +$1.95K 0.02% 551
2024
Q2
$225K Buy
+4,296
New +$188K 0.02% 544

Other funds holding HALO

Fifth Third Wealth Advisors's HALO Position: Q3 2026 in Review

Fifth Third Wealth Advisors increased its Halozyme (HALO) stake by 3.5% in Q3 2026, buying an estimated $14.6K and bringing the position to 4,515 shares worth $498K. The position accounts for 0.01% of the portfolio, ranked #527.

Fifth Third Wealth Advisors first reported a position in HALO in Q2 2024 and has held it in 10 quarters since. 290 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Fifth Third Wealth Advisors held 4,515 shares of Halozyme worth $498K as of Q3 2026.
  • Fifth Third Wealth Advisors bought 151 Halozyme shares in Q3 2026, an estimated $14.6K.
  • Halozyme made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #527 holding.
  • Fifth Third Wealth Advisors first reported a position in Halozyme in Q2 2024 and has held it in 10 quarters since.
  • 290 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.